|
1
|
Andersen DK: Diabetes and cancer: Placing
the association in perspective. Curr Opin Endocrinol Diabetes Obes.
20:81–86. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sundaram S, Johnson AR and Makowski L:
Obesity, metabolism and the microenvironment: Links to cancer. J
Carcinog. 12:192013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ogden CL, Carroll MD, Curtin LR, McDowell
MA, Tabak CJ and Flegal KM: Prevalence of overweight and obesity in
the United States, 1999–2004. JAMA. 295:1549–1555. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chu NF: Prevalence of obesity in Taiwan.
Obes Rev. 6:271–274. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bergström A, Pisani P, Tenet V, Wolk A and
Adami HO: Overweight as an avoidable cause of cancer in Europe. Int
J Cancer. 91:421–430. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Calle EE, Rodriguez C, Walker-Thurmond K
and Thun MJ: Overweight, obesity and mortality from cancer in a
prospectively studied cohort of U.S. adults. N Engl J Med.
348:1625–1638. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin.
58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Renehan AG, Tyson M, Egger M, Heller RF
and Zwahlen M: Body-mass index and incidence of cancer: A
systematic review and meta-analysis of prospective observational
studies. Lancet. 371:569–578. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Feng YH, Velazquez-Torres G, Gully C, Chen
J, Lee MH and Yeung SC: The impact of type 2 diabetes and
antidiabetic drugs on cancer cell growth. J Cell Mol Med.
15:825–836. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Feng YH, Lin CY, Huang WT, Wu CL, Fang JL,
et al: Diabetes mellitus impairs the response to intra-arterial
chemotherapy in hepatocellular carcinoma. Med Oncol. 28:1080–1088.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Coates RJ, Clark WS, Eley JW, Greenberg
RS, Huguley CM and Brown RL: Race, nutritional status, and survival
from breast cancer. J Natl Cancer Inst. 82:1684–1692. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Caan BJ, Kwan ML, Hartzell G, Castillo A,
Slattery ML, Sternfeld B and Weltzien E: Pre-diagnosis body mass
index, post-diagnosis weight change, and prognosis among women with
early stage breast cancer. Cancer Causes Control. 19:1319–1328.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kroenke CH, Chen WY, Rosner B and Holmes
MD: Weight, weight gain, and survival after breast cancer
diagnosis. J Clin Oncol. 23:1370–1378. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Okwan-Duodu D, Umpierrez GE, Brawley OW
and Diaz R: Obesity-driven inflammation and cancer risk: Role of
myeloid derived suppressor cells and alternately activated
macrophages. Am J Cancer Res. 3:21–33. 2013.PubMed/NCBI
|
|
15
|
Giles ED, Wellberg EA, Astling DP,
Anderson SM, Thor AD, Jindal S, Tan AC, Schedin PS and Maclean PS:
Obesity and overfeeding affecting both tumor and systemic
metabolism activates the progesterone receptor to contribute to
postmenopausal breast cancer. Cancer Res. 72:6490–6501. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kaviani A, Neishaboury M, Mohammadzadeh N,
Ansari-Damavandi, et al: Effects of obesity on presentation of
breast cancer, lymph node metastasis and patient survival: A
retrospective review. Asian Pac J Cancer Prev. 14:2225–2229. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pandey PR, Xing F, Sharma S, Watabe M, Pai
SK, Iiizumi-Gairani M, Fukuda K, Hirota S, Mo YY and Watabe K:
Elevated lipogenesis in epithelial stem-like cell confers survival
advantage in ductal carcinoma in situ of breast cancer. Oncogene.
32:5111–5122. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kuhajda FP, Jenner K, Wood FD, Hennigar
RA, Jacobs LB, Dick JD and Pasternack GR: Fatty acid synthesis: A
potential selective target for antineoplastic therapy. Proc Natl
Acad Sci USA. 91:6379–6383. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Furuta E, Pai SK, Zhan R, Bandyopadhyay S,
Watabe M, Mo YY, Hirota S, Hosobe S, Tsukada T, Miura K, et al:
Fatty acid synthase gene is up-regulated by hypoxia via activation
of Akt and sterol regulatory element binding protein-1. Cancer Res.
68:1003–1011. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Alo' PL, Visca P, Marci A, Mangoni A,
Botti C and Di Tondo U: Expression of fatty acid synthase (FAS) as
a predictor of recurrence in stage I breast carcinoma patients.
Cancer. 77:474–482. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang D, Tai LK, Wong LL, Chiu LL, Sethi
SK and Koay ES: Proteomic study reveals that proteins involved in
metabolic and detoxification pathways are highly expressed in
HER-2/neu-positive breast cancer. Mol Cell Proteomics. 4:1686–1696.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vazquez-Martin A, Colomer R, Brunet J and
Menendez JA: Pharmacological blockade of fatty acid synthase (FASN)
reverses acquired autoresistance to trastuzumab (Herceptin by
transcriptionally inhibiting ‘HER2 super-expression’ occurring in
high-dose trastuzumab-conditioned SKBR3/Tzb100 breast cancer cells.
Int J Oncol. 31:769–776. 2007.PubMed/NCBI
|
|
23
|
Matsuzaka T, Shimano H, Yahagi N, Kato T,
Atsumi A, Yamamoto T, Inoue N, Ishikawa M, Okada S, Ishigaki N, et
al: Crucial role of a long-chain fatty acid elongase, Elovl6, in
obesity-induced insulin resistance. Nat Med. 13:1193–1202. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Muir K, Hazim A, He Y, Peyressatre M, Kim
DY, Song X and Beretta L: Proteomic and lipidomic signatures of
lipid metabolism in NASH-associated hepatocellular carcinoma.
Cancer Res. 73:4722–4731. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cheng L, Nagabhushan M, Pretlow TP, Amini
SB and Pretlow TG: Expression of E-cadherin in primary and
metastatic prostate cancer. Am J Pathol. 148:1375–1380.
1996.PubMed/NCBI
|
|
26
|
Cheng L, Pan CX, Zhang JT, Zhang S, Kinch
MS, Li L, Baldridge LA, Wade C, Hu Z, Koch MO, et al: Loss of
14-3-3sigma in prostate cancer and its precursors. Clin Cancer Res.
10:3064–3068. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang Z, Willett WC, Colditz GA, Hunter
DJ, Manson JE, Rosner B, Speizer FE and Hankinson SE: Waist
circumference, waist:hip ratio, and risk of breast cancer in the
Nurses' Health Study. Am J Epidemiol. 150:1316–1324. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Reeves GK, Pirie K, Beral V, Green J,
Spencer E and Bull D: Million Women Study Collaboration: Cancer
incidence and mortality in relation to body mass index in the
Million Women Study: Cohort study. BMJ. 335:11342007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zaidi N, Lupien L, Kuemmerle NB, Kinlaw
WB, Swinnen JV and Smans K: Lipogenesis and lipolysis: The pathways
exploited by the cancer cells to acquire fatty acids. Prog Lipid
Res. 52:585–589. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chalbos D, Joyeux C, Galtier F, Escot C,
Chambon M, Maudelonde T and Rochefort H: Regulation of fatty acid
synthetase by progesterone in normal and tumoral human mammary
glands. Rev Esp Fisiol. 46:43–46. 1990.PubMed/NCBI
|
|
31
|
Wang Y, Kuhajda FP, Li JN, Pizer ES, Han
WF, Sokoll LJ and Chan DW: Fatty acid synthase (FAS) expression in
human breast cancer cell culture supernatants and in breast cancer
patients. Cancer Lett. 167:99–104. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Agostini M, Almeida LY, Bastos DC, Ortega
RM, Moreira FS, Seguin F, Zecchin KG, Raposo HF, Oliveira HC,
Amoêdo ND, et al: The fatty acid synthase inhibitor orlistat
reduces the growth and metastasis of orthotopic tongue oral
squamous cell carcinomas. Mol Cancer Ther. 13:585–595. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wong JM, Chi SN, Marcus KJ, Levine BS,
Ullrich NJ, MacDonald S, Lechpammer M and Goumnerova LC: Germinoma
with malignant transformation to nongerminomatous germ cell tumor.
J Neurosurg Pediatr. 6:295–298. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Migita T, Okabe S, Ikeda K, Igarashi S,
Sugawara S, et al: Inhibition of ATP citrate lyase induces an
anticancer effect via reactive oxygen species: AMPK as a predictive
biomarker for therapeutic impact. Am J Pathol. 182:1800–1810. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Migita T, Okabe S, Ikeda K, Igarashi S,
Sugawara S, Tomida A, Soga T, Taguchi R and Seimiya H: Inhibition
of ATP citrate lyase induces triglyceride accumulation with altered
fatty acid composition in cancer cells. Int J Cancer. 135:37–47.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kessler SM, Simon Y, Gemperlein K,
Gianmoena K, Cadenas C, Zimmer V, Pokorny J, Barghash A, Helms V,
van Rooijen N, et al: Fatty acid elongation in non-alcoholic
steatohepatitis and hepatocellular carcinoma. Int J Mol Sci.
15:5762–5773. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Matsuzaka T and Shimano H: Elovl6: A new
player in fatty acid metabolism and insulin sensitivity. J Mol Med
(Berl). 87:379–384. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shimamura K, Nagumo A, Miyamoto Y,
Kitazawa H, Kanesaka M, Yoshimoto R, Aragane K, Morita N, Ohe T,
Takahashi T, et al: Discovery and characterization of a novel
potent, selective and orally active inhibitor for mammalian ELOVL6.
Eur J Pharmacol. 630:34–41. 2010. View Article : Google Scholar : PubMed/NCBI
|
